Mavenclad

Affordable Pharmaceuticals LLC, based in Braintree, MA, has been a trusted provider of highly effective and affordable laxatives and bowel preparations since 2005. As a leading US-focused generic pharmaceutical company, they specialize in the core therapeutic class of gastroenterology, with a particular focus on colorectal cancer prevention. With all their products manufactured in an FDA approved plant in Massachusetts, Affordable Pharmaceuticals is committed to making quality pharmaceuticals accessible to patients. As a subsidiary of Braintree Laboratories, a market leader in the gastroenterology space, Affordable Pharmaceuticals benefits from their parent company's expertise in colonoscopy preps. They offer a range of authorized generic products, including PEG-3350 and Electrolytes for Oral Solution, Sodium Chloride, Sodium Bicarbonate, and Potassium Chloride for Oral Solution, and Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Oral Solution. With a dedicated team of 100 employees, Affordable Pharmaceuticals is dedicated to the cause of colon cancer prevention and ensuring patient safety.Generated from the website

Braintree Laboratories, Inc., a part of Sebela Pharmaceuticals, is headquartered in Roswell, Georgia, with additional locations in Dublin, Ireland, and Braintree, Massachusetts. The company focuses on research and development in various therapeutic areas, including gastrointestinal health, women's health, and long-acting reversible contraception. With a commitment to innovation and patient care, Braintree Laboratories aims to advance healthcare solutions through its diverse product pipeline and strategic development initiatives. The organization values diversity and inclusion, fostering an environment that encourages advocacy and collaboration within the healthcare community. Generated from the website

Daiichi Sankyo Inc, located in Marshfield, MA, is a prominent player in the pharmaceutical industry, focusing on research and development to advance healthcare solutions. The company is dedicated to patient-centric initiatives and sustainability efforts aligned with the Sustainable Development Goals (SDGs). Committed to corporate governance and operational responsibility, Daiichi Sankyo emphasizes innovation and transparency in its research endeavors. Through its various programs, the company aims to contribute significantly to the field of medicine while maintaining a sustainable approach to its operations. Generated from the website